Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Validation of Reactive Stroma as an Adverse Prognostic Factor for Gleason Grade 3+3=6 and 3+4=7 Prostatic Adenocarcinomas (PCA) In the Canary Retrospective Radical Prostatectomy (RP) Cohort
Validation of Reactive Stroma as an Adverse Prognostic Factor for Gleason Grade 3+3=6 and 3+4=7 Prostatic Adenocarcinomas (PCA) In the Canary Retrospective Radical Prostatectomy (RP) Cohort McKenney, J. K., Wei, W., Hawley, S. J., Auman, H., Newcomb, L., Boyer, H., Fazli, L., Simko, J., Hurtado-Coll, A., Troyer, D., Tretiakova, M. S., Vakar-Lopez, F., Carroll, P. R., Cooperberg, M. R., Gleave, M. E., Lance, R., Lin, D., Nelson, P. S., Thompson, I., True, L., Feng, Z., Brooks, J. D. NATURE PUBLISHING GROUP. 2016: 249AView details for Web of Science ID 000369270701376